High Tide Sets September 14 for Q3 2026 Earnings Release
Event summary
- High Tide Inc. will release its Q3 2026 financial results on September 14, 2026, after market close.
- The company operates 229 Canna Cabana retail locations in Canada, holding a 12% market share.
- Remexian Pharma GmbH, a subsidiary, holds a 14% share of the German medical cannabis market.
- High Tide was named one of Canada's Top Growing Companies by the Globe and Mail in 2025.
The big picture
High Tide's strategic focus on retail and international expansion positions it as a key player in the cannabis industry. Its growing market share in Canada and significant presence in Germany highlight its ability to navigate both domestic and international markets. The company's consistent recognition as a top-growing entity underscores its operational efficiency and strategic agility.
What we're watching
- Retail Expansion
- How High Tide's growing retail footprint in Canada will impact market share and revenue.
- International Growth
- Whether High Tide can sustain its expansion in the German medical cannabis market.
- Market Dynamics
- The pace at which High Tide can scale its operations to maintain its position as a top-growing company.